Evidence map›Paper›PMID 28100068›Full record

ArticleAIDS care2017

Prevalence, patterns, and correlates of HIV disclosure among TB-HIV patients initiating antiretroviral therapy in Lesotho.

Eleanor Hayes-Larson, Yael Hirsch-Moverman, Suzue Saito, Koen Frederix, Blanche Pitt, Bridget Llang Maama, Andrea A Howard

Open access · greenAbstract read
In one paragraph

Article in AIDS care, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Eleanor Hayes-Larsona ICAP, Mailman School of Public Health, Columbia University , New York , NY , USA.
Yael Hirsch-Movermana ICAP, Mailman School of Public Health, Columbia University , New York , NY , USA.
Suzue Saitoa ICAP, Mailman School of Public Health, Columbia University , New York , NY , USA.
Koen Frederixa ICAP, Mailman School of Public Health, Columbia University , New York , NY , USA.
Blanche Pitta ICAP, Mailman School of Public Health, Columbia University , New York , NY , USA.
Bridget Llang Maamac National Tuberculosis Control Programme, Lesotho Ministry of Health , Maseru , Lesotho.
Andrea A Howarda ICAP, Mailman School of Public Health, Columbia University , New York , NY , USA.
Columbia University · USMinistry of Health · LS

Funding

Global HIV Implementation Science Research Training Grant RenewalT32AI114398 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Yael R Hirsch-Moverman · 2014 to 2026
$4.1M
Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)K01AI104351 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HIRSCH-MOVERMAN, YAEL R · 2014 to 2018
$635k
NIAID NIH HHS K01 AI104351NIAID NIH HHS T32 AI114398PEPFAR
6 · The paper itself

Abstract

Disclosure of HIV-positive status has important implications for patient outcomes and preventing HIV transmission, but has been understudied in TB-HIV patients. We assessed disclosure patterns and correlates of non-disclosure among adult TB-HIV patients initiating ART enrolled in the START Study, a mixed-methods cluster-randomized trial conducted in Lesotho, which evaluated a combination intervention package (CIP) versus standard of care. Interviewer-administered questionnaire data were analyzed to describe patterns of disclosure. Patient-related factors were assessed for association with non-disclosure to anyone other than a health-care provider and primary partners using generalized linear mixed models. Among 371 participants, 95% had disclosed their HIV diagnosis to someone other than a health-care provider, most commonly a spouse/primary partner (76%). Age, TB knowledge, not planning to disclose TB status, greater perceived TB stigma, and CIP were associated with non-disclosure in unadjusted models (p < .1). In adjusted models, all point estimates were similar and greater TB knowledge (adjusted odds ratio [aOR] 0.59, 95% confidence interval [CI] 0.39-0.90) and CIP (aOR 0.20, 95% CI 0.05-0.79) remained statistically significant. Among 220 participants with a primary partner, 76% had disclosed to that partner. Significant correlates of partner non-disclosure (p < .1) in unadjusted analyses included being female, married/cohabitating, electricity at home, not knowing if partner was HIV-positive, and TB knowledge. Adjusted point estimates were largely similar, and being married/cohabitating (aOR 0.03, 95% CI 0.01-0.12), having electricity at home (aOR 0.38, 95% CI 0.17-0.85) and greater TB knowledge (aOR 0.76, 95% CI 0.59-0.98) remained significant. In conclusion, although nearly all participants reported disclosing their HIV status to someone other than a health-care provider at ART initiation, nearly a quarter of participants with a primary partner had not disclosed to their partner. Additional efforts to support HIV disclosure (e.g., counseling) may be needed for TB-HIV patients, particularly for women and those unaware of their partners' status.

Indexed as

Antiretroviral Therapy, Highly ActiveSelf DisclosureSocial StigmaTruth DisclosureAdultCounselingCross-Sectional StudiesFemaleHIV InfectionsHumansLesothoMiddle AgedPrevalenceSexual PartnersSurveys and QuestionnairesTuberculosisdisclosureHIVsexual partnershipsTB-HIV co-infectiontuberculosis

Identifiers

PMID28100068
PMCPMC5469711
OpenAlexW2579439163

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.